REGN
Regeneron Pharmaceuticals, Inc. (REGN) Investor Questions
Review Regeneron Pharmaceuticals, Inc. (REGN) faq with server-rendered company data, supporting context and links to related investor research.
- Company
- Regeneron Pharmaceuticals, Inc.
- Sector
- Healthcare
- Industry
- Biotechnology
- Overall BTI score
- 72
- Annual revenue
- $14.34B
- Annual net income
- $4.50B
- Annual free cash flow
- $4.08B
Regeneron Pharmaceuticals, Inc. (REGN) Investor Questions research
Regeneron Pharmaceuticals, Inc. trades under the ticker REGN. The company is classified in the Healthcare sector and the Biotechnology industry.
Investors commonly review REGN through its earnings trend, revenue, free cash flow, balance sheet, valuation and historical risk. The linked research sections provide a separate crawlable page for each data-rich topic.